Literature DB >> 16996334

Clinical presentation of patients with eosinophilic inflammation of the esophagus.

Sachin Baxi1, Sandeep K Gupta, Nancy Swigonski, Joseph F Fitzgerald.   

Abstract

BACKGROUND: Allergic eosinophilic esophagitis (AEE) is defined by a dense infiltrate of eosinophils within the esophageal mucosa and the absence of pathological gastroesophageal reflux.
OBJECTIVE: To characterize a pediatric population with AEE to determine if AEE can be diagnosed based on history; to compare patients with varying degrees of esophageal eosinophilic inflammation to determine if moderate esophageal inflammation is part of a continuum of AEE.
DESIGN: Medical records of 112 patients with eosinophils on esophageal biopsy specimens were reviewed. Patients were grouped according to eosinophils per high power field (eos/hpf): group 1 (1-5 eos/hpf, n = 31), group 2 (6-14 eos/hpf, n = 13), and group 3 (> or =15 eos/hpf, n = 68) and compared.
SETTING: University Children's Hospital. PATIENTS: Children and adolescents with eosinophils on esophageal mucosal biopsy specimens.
INTERVENTIONS: Analysis of clinical information. MAIN OUTCOME MEASUREMENTS: Clinical characterization of patients with esophageal eosinophilia.
RESULTS: There was no significant difference in patient demographics. Patients in groups 2 and 3 had multiple food allergens identified. Patients in group 3 with a positive type I allergic response were significantly younger than those with a negative response (mean, 4.6 years old vs mean, 8.5 years old; P = .0065). In group 2, 3 of 13 patients responded histologically to acid-suppressive therapy, whereas 6 patients had improved histology with corticosteroids; 4 of these 6 patients had not responded histologically to acid-suppression. LIMITATIONS: Retrospective study.
CONCLUSIONS: History and clinical presentation were not useful in predicting the severity of histologic esophageal inflammation in this cohort. Patients with moderate esophageal eosinophilia (group 2) exhibited a variable response to medical therapy.

Entities:  

Mesh:

Year:  2006        PMID: 16996334     DOI: 10.1016/j.gie.2006.03.931

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  19 in total

Review 1.  Allergic eosinophilic esophagitis.

Authors:  Kevin C Bax; Sandeep K Gupta
Journal:  Indian J Pediatr       Date:  2006-10       Impact factor: 1.967

2.  Endoscopic findings in patients presenting with dysphagia: analysis of a national endoscopy database.

Authors:  Chaya Krishnamurthy; Kristen Hilden; Kathryn A Peterson; Nora Mattek; Douglas G Adler; John C Fang
Journal:  Dysphagia       Date:  2011-06-15       Impact factor: 3.438

3.  Eosinophilic esophagitis in children and adolescents: epidemiology, clinical presentation and seasonal variation.

Authors:  Serge Alexander Sorser; Mohammed Barawi; Karen Hagglund; Mohammad Almojaned; Hernando Lyons
Journal:  J Gastroenterol       Date:  2012-05-23       Impact factor: 7.527

4.  Assessing the incidence trend and characteristics of eosinophilic esophagitis in children in Olmsted County, Minnesota.

Authors:  S Hommeida; R M Grothe; Y Hafed; R J Lennon; C D Schleck; J A Alexander; D A Katzka; I Absah
Journal:  Dis Esophagus       Date:  2018-12-01       Impact factor: 3.429

5.  Pediatric Eosinophilic Esophagitis Symptom Scores (PEESS v2.0) identify histologic and molecular correlates of the key clinical features of disease.

Authors:  Lisa J Martin; James P Franciosi; Margaret H Collins; J Pablo Abonia; James J Lee; Kevin A Hommel; James W Varni; J Tommie Grotjan; Michael Eby; Hua He; Keith Marsolo; Philip E Putnam; Jose M Garza; Ajay Kaul; Ting Wen; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2015-06       Impact factor: 10.793

Review 6.  Environmental factors and eosinophilic esophagitis.

Authors:  Elizabeth T Jensen; Evan S Dellon
Journal:  J Allergy Clin Immunol       Date:  2018-05-02       Impact factor: 10.793

7.  Misregulation of suppressors of cytokine signaling in eosinophilic esophagitis.

Authors:  Ma Paz Zafra; Natally Cancelliere; Pablo Rodríguez del Río; Mónica Ruiz-García; Laura Estévez; Victoria Andregnette; Silvia Sánchez-García; Ana Fiandor; Elena Collantes; Joaquín Sastre; Santiago Quirce; María Dolores Ibáñez; Victoria del Pozo
Journal:  J Gastroenterol       Date:  2012-12-11       Impact factor: 7.527

Review 8.  Eosinophilic Esophagitis: an Important Comorbid Condition of Asthma?

Authors:  Sandy R Durrani; Vincent A Mukkada; Theresa W Guilbert
Journal:  Clin Rev Allergy Immunol       Date:  2018-08       Impact factor: 8.667

Review 9.  Eosinophilic esophagitis.

Authors:  Anand R Gupte; Peter V Draganov
Journal:  World J Gastroenterol       Date:  2009-01-07       Impact factor: 5.742

10.  The extremely narrow-caliber esophagus is a treatment-resistant subphenotype of eosinophilic esophagitis.

Authors:  Swathi Eluri; Thomas M Runge; Cary C Cotton; Caitlin M Burk; W Asher Wolf; John T Woosley; Nicholas J Shaheen; Evan S Dellon
Journal:  Gastrointest Endosc       Date:  2015-12-01       Impact factor: 9.427

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.